{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:40:10Z","timestamp":1749948010277,"version":"3.41.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Mitochondrial toxicity resulting in myopathy and lactic acidosis has been described in antiretroviral (ARV)-exposed patients. We hypothesized that myopathy in HIV-infected, ARV-treated children would be associated with metabolic (acylcarnitines) and genetic (variants in metabolic genes) markers of dysfunctional fatty acid oxidation (FAO).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Acylcarnitine profiles (ACP) were analyzed for 74 HIV-infected children on nucleoside reverse transcriptase inhibitor (NRTI)-containing ARV. Thirty-seven participants with \u22652 creatine kinase measurements &gt;500 IU (n = 18) or evidence of echocardiographic cardiomyopathy (n = 19) were matched with 37 participants without myopathy. Single nucleotide polymorphisms (SNPs) in FAO genes were also evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Abnormal ACP was 73% (95% CI: 56%\u201386%) and 62% (95% CI: 45%\u201378%) in the myopathic and nonmyopathic groups, respectively. No significant association was found between myopathy and having an abnormal ACP (OR = 2.10, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.22). In univariate analysis, a 1-year increase in NRTI use was associated with a 20% increase in odds of at least 1 ACP abnormality [OR (95% CI) = 1.20 (1.03\u20131.41); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02), and a 1-year increase in protease inhibitor use was associated with 28% increase in the odds of having at least 1 ACP abnormality [OR (95% CI) = 1.28 (1.07\u20131.52); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006). Three SNPs, all in the gene for the carnitine transporter (<jats:italic toggle=\"yes\">SLC22A5<\/jats:italic>), were associated with the cardiomyopathy phenotype.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>FAO appears to be altered in HIV-infected children with and without myopathy, but abnormal FAO does not fully explain myopathy in ARV-exposed children. Further study of <jats:italic toggle=\"yes\">SLC22A5<\/jats:italic> variation in ARV-exposed people is warranted carnitine transporter dysfunction-related cardiomyopathy may be treatable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003586","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T17:00:10Z","timestamp":1653670810000},"page":"e306-e311","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-5029","authenticated-orcid":false,"given":"Brian","family":"Kirmse","sequence":"first","affiliation":[{"name":"Division of Genetics & Metabolism, Children\u2019s National Health System, Washington, DC"},{"name":"Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Hobbs","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Mississippi Medical Center, Jackson, MS"},{"name":"Division of Pediatric Infectious Disease and Immunology, New York University\/Langone School of Medicine, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Aaron","sequence":"additional","affiliation":[{"name":"Harvard TH Chan School of Public Health, Center for Biostatistics in AIDS Research, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-4335","authenticated-orcid":false,"given":"Grace","family":"Montepiedra","sequence":"additional","affiliation":[{"name":"Harvard TH Chan School of Public Health, Center for Biostatistics in AIDS Research, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Summar","sequence":"additional","affiliation":[{"name":"Division of Genetics & Metabolism, Children\u2019s National Health System, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[{"name":"Harvard TH Chan School of Public Health, Center for Biostatistics in AIDS Research, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin J.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Iowa, College of Public Health, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3265-3826","authenticated-orcid":false,"given":"Russell","family":"Van Dyke","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine, New Orleans, LA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunli","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Genetics & Genomic Sciences, Mount Sinai School of Medicine, Laboratory of Biochemical Genetics, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli K.","family":"Ryckman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Iowa, College of Public Health, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Borkowsky","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease and Immunology, New York University\/Langone School of Medicine, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Pediatric HIV\/AIDS Cohort Study","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","article-title":"The in-depth evaluation of suspected mitochondrial disease.","volume":"94","author":"Haas","year":"2008","journal-title":"Mol Genet Metab"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/meta.2002.30521","article-title":"Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders.","volume":"51","author":"Sim","year":"2002","journal-title":"Metabolism"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/INF.0b013e31827030a6","article-title":"Abnormal newborn screening data and acylcarnitines in HIV\/ARV-exposed infants.","volume":"32","author":"Kirmse","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2334-13-203","article-title":"Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.","volume":"13","author":"Cassol","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10545-009-9001-1","article-title":"Fatty acid oxidation disorders: outcome and long-term prognosis.","volume":"33","author":"Wilcken","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3945\/jn.108.103754","article-title":"Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.","volume":"139","author":"Adams","year":"2009","journal-title":"J Nutr"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines: reflecting or inflicting insulin resistance?","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.","volume":"163","author":"Shah","year":"2012","journal-title":"Am Heart J"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00439-014-1450-4","article-title":"Metabolic heritability at birth: implications for chronic disease research.","volume":"133","author":"Ryckman","year":"2014","journal-title":"Hum Genet"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00467-011-2097-1","article-title":"Chronic kidney disease associated with perinatal HIV infection in children and adolescents.","volume":"27","author":"Purswani","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31819ca49a","article-title":"Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.","volume":"28","author":"Andiman","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","article-title":"Acylcarnitine profile analysis.","volume":"10","author":"Rinaldo","year":"2008","journal-title":"Genet Med"},{"key":"R14-20250614","first-page":"Unit 17.8.1","article-title":"Acylcarnitine analysis by tandem mass spectrometry.","volume":"17","author":"Smith","year":"2010","journal-title":"Curr Protoc Hum Genet"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10354","article-title":"Human metabolic individuality in biomedical and pharmaceutical research.","volume":"477","author":"Suhre","year":"2011","journal-title":"Nature"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/aid.2015.0112","article-title":"Acylcarnitine profiles in HIV-exposed, uninfected neonates in the United States.","volume":"32","author":"Kirmse","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/INF.0b013e31827030a6","article-title":"Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants.","volume":"32","author":"Kirmse","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic flexibility in health and disease.","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metab"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.52.2.366","article-title":"Short-chain acyl-CoA dehydrogenase deficiency: a cause of ophthalmoplegia and multicore myopathy.","volume":"52","author":"Tein","year":"1999","journal-title":"Neurology"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM198411083111906","article-title":"Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency.","volume":"311","author":"Turnbull","year":"1984","journal-title":"N Engl J Med"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1750-1172-7-68","article-title":"Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.","volume":"7","author":"Magoulas","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbalip.2014.04.001","article-title":"Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism.","volume":"1841","author":"Schooneman","year":"2014","journal-title":"Biochim Biophys Acta"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:08:57Z","timestamp":1749946137000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003586","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}